Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence

Published:2023-11 Issue: Volume:191 Page:104104
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Zambelli A.,Gallerani E.,Garrone O.,Pedersini R.,Rota Caremoli E.,Sagrada P.,Sala E.,Cazzaniga ME

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference33 articles.

1. Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update;Allison;J. Clin. Oncol.,2020

2. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging;Amin;CA Cancer J. Clin.,2017

3. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions;Antoniou,2008

4. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021;Burstein;Ann. Oncol.,2021

5. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Cardoso;Ann. Oncol.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer;Cancer Management and Research;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP